FBRX — Forte Biosciences Inc

Founder-Led

Stock analysis, trade plans, and proprietary indicators by Trend Edge.

About Forte Biosciences Inc

Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company's lead product candidate is the FB-102, a proprietary anti-CD122 monoclonal antibody therapeutic candidate for various autoimmune and autoimmune-related indications, such as celiac disease, vitiligo, alopecia areata, and type 1 diabetes. Forte Biosciences, Inc. Read full Trend Edge analysis →

Trend Edge Proprietary Indicators

Key Metrics

Current Price$21.47
Market Cap$416M
Float18.1M
Shares Outstanding20.5M
vs. Analyst Target+196.9% to analyst PT
Dividend RateNone
Analyst Target Price$63.75 (4 analysts)

Financial History

Annual Revenue & Earnings History

YearRevenueNet IncomeGross ProfitEBITDA
2020 N/A -$46.5M -$54,000 -$46.4M
2021 N/A -$21.7M -$36,000 -$21.4M
2022 N/A -$13.9M N/A -$13.9M
2023 N/A -$31.5M -$9,000 -$32.5M
2024 N/A -$35.5M -$39,000 -$35.4M
2025 N/A -$69.4M -$64,000 -$70.6M

Recent Quarterly Revenue & Net Income

QuarterRevenueNet Income
Jun 2025 N/A -$11.2M
Sep 2025 N/A -$17.7M
Dec 2025 N/A -$24.8M
Mar 2026 N/A -$22.1M

Ownership & Float

Insider Ownership2.1%
Institutional Ownership70.5%
Short Float5.7%
% of All Funds Holding0.78%
Number of Funds Holding64

Current Moving Averages

Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.

TimeframeSMAValueTrend Context
Weekly10-Week SMA$26.59Near-term / short-term trend
Weekly40-Week SMA$22.40Medium-term trend
Weekly80-Week SMA$17.39Cyclical trend (business cycle)
Weekly200-Week SMA$18.69Secular trend (multi-year)
Monthly10-Month SMA$21.83Near-term monthly trend
Monthly20-Month SMA$16.93Medium-term monthly trend
Monthly40-Month SMA$17.47Secular monthly trend

Volume Shelves — Support & Resistance

Trend Edge identifies volume shelves: price zones where historically elevated trading volume creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.

Price LevelTypeVolume RatioAge
$26.90 resistance 1.03x 0 months ago
$18.90 support 1.80x 4 months ago
$13.00 support 1.39x 5 months ago
$10.80 support 1.34x 7 months ago
$4.50 support 9.75x 17 months ago

Historical Earnings Reactions (37 events)

TimeframeAvg ReturnMedianWin RateBestWorst
Gap -1.03% -0.25% 35.14% 6.30% -9.91%
1 Day -0.49% 0.18% 54.05% 15.63% -20.51%
1 Week 10.49% 3.06% 64.86% 186.74% -18.21%
2 Weeks 13.28% 3.40% 63.89% 320.43% -44.63%
1 Month 11.92% 4.07% 58.33% 236.02% -86.53%

Next earnings: August 2, 2026 (66 days away)

Seasonality & Day-of-Week Patterns

Monthly Seasonality

MonthAvg ReturnWin RateSamples
Jan-2.1%33.3%9
Feb10.9%44.4%9
Mar0.2%44.4%9
Apr-4.6%44.4%9
May-2.7%55.6%9
Jun2.7%33.3%9
Jul-4.5%22.2%9
Aug1.5%55.6%9
Sep-10.6%33.3%9
Oct-15.3%11.1%9
Nov49.5%55.6%9
Dec4.5%55.6%9

Day-of-Week Tendencies

DayAvg ReturnWin RateSamples
Monday -0.37% 43.1% 429
Tuesday 0.12% 47.7% 472
Wednesday 0.08% 45.5% 468
Thursday -0.10% 41.5% 460
Friday 0.44% 48.8% 461

Top Institutional Holders

Institutional holder breakdown coming soon.

Total institutional ownership: 70.5%

Insider Transactions — Smart Summary

Total insider ownership: 2.1%

Founder-led management: Paul A. Wagner (CEO, President & Chairman)

12-Month Insider Activity Summary

Total Filings1
Net Value+$250,633.196
Net Shares Change9,901
% of Float0.1%
C-Suite Filings1
Clusters Detected0

Key Insiders

NameTitleNet ValueFilingsActivity
Riley Antony A CHIEF FINANCIAL OFFICER +$250,633.196 1 1 buy

Significant Filings

DateInsiderTitleNet ValuePrice After
2026-01-02 Riley Antony A CHIEF FINANCIAL OFFICER +$250,633.196 Transaction at $26.80, now -19.9%

View full insider transaction history on Trend Edge →

AI Consult Analysis

Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for Forte Biosciences Inc (FBRX) powered by Claude Opus — Anthropic's most capable AI model. The analysis covers five layers: technical analysis (near-term, medium-term, cyclical, and secular trend, momentum, volume shelf support and resistance, breakout and breakdown signals), qualitative analysis (business model, competitive moat, sector dynamics), insider sentiment (buy and sell signals from executive and director transactions), share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and fundamental analysis (valuation, revenue growth, profit margin, earnings quality).

AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit, stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward. Whether you are building a long position, initiating a short, or looking for a reversal setup, AI Consult identifies the highest-probability signal from the current trend.

Get the full AI Consult analysis for FBRX on Trend Edge →